Previous Article | Next Article 
Journal of Bacteriology, August 2001, p. 4718-4726, Vol. 183, No. 16
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.16.4718-4726.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Insertion-Duplication Mutagenesis of
Neisseria: Use in Characterization of DNA Transfer Genes in
the Gonococcal Genetic Island
Holly L.
Hamilton,
Kevin J.
Schwartz, and
Joseph P.
Dillard*
Department of Medical Microbiology and
Immunology, University of Wisconsin
Madison Medical School,
Madison, Wisconsin 53706
Received 5 February 2001/Accepted 24 May 2001
 |
ABSTRACT |
We created plasmids for use in insertion-duplication mutagenesis
(IDM) of Neisseria gonorrhoeae. This mutagenesis method has the advantage that it requires only a single cloning step prior to
transformation into gonococci. Chromosomal DNA cloned into the plasmid
directs insertion into the chromosome at the site of homology by a
single-crossover (Campbell-type) recombination event. Two of the
vectors contain an erythromycin resistance gene, ermC, with
a strong promoter and in an orientation such that transcription will
proceed into the cloned insert. Thus, these plasmids can be used to
create insertions that are effectively nonpolar on the transcription of
downstream genes. In addition to the improved ermC, the
vector contains two copies of the neisserial DNA uptake sequence to
facilitate high-frequency DNA uptake during transformation. Using
various chromosomal DNA insert sizes, we have determined that even
small inserts can target insertion mutation by this method and that the
insertions are stably maintained in the gonococcal chromosome. We have
used IDM to create knockouts in two genes in the gonococcal genetic
island (GGI) and to clone additional regions of the GGI by a
chromosome-walking procedure. Phenotypic characterization of
traG and traH mutants suggests a role for the
encoded proteins in DNA secretion by a novel type IV secretion system.
 |
INTRODUCTION |
Because many standard genetic tools
do not function in Neisseria gonorrhoeae, the construction
of special tools for manipulating its genome is a necessity. N. gonorrhoeae is highly competent for natural transformation
(13, 37). Therefore several mechanisms for mutagenesis of
N. gonorrhoeae that rely on transformation have been
developed previously, including shuttle mutagenesis (34),
direct cloning of antibiotic resistance markers (46), and
direct transformation of constructed mutations without selectable markers (14). Shuttle mutagenesis is highly useful in that
it offers a method for transposon mutagenesis in an organism that otherwise cannot be transposon mutagenized (34, 35). The
procedure, however, requires several steps. The gene of interest must
be cloned into an Escherichia coli plasmid, and the plasmid
is then subjected to transposon mutagenesis in E. coli.
Screening to identify mutants takes place, and finally the vector is
transferred to the organism of interest, where homologous recombination
results in the incorporation of the mutation into the chromosome. For efficient transformation of gonococci, the transposon must be flanked
by a significant amount of gonococcal DNA (~500 bp). Therefore, the
original target must generally contain more than a kilobase of cloned
DNA. The method of direct transformation of constructed mutants in
gonococcal genes has similar difficulties and requires extensive
screening to find a mutant of interest.
In this paper we describe the development and use of
insertion-duplication mutagenesis (IDM) plasmids for producing targeted mutations in N. gonorrhoeae. IDM utilizes chromosomal
fragments cloned into plasmids to target insertion into the recipient
chromosome by homologous recombination, resulting in the insertion of
the vector between duplicated target sequences (25) (see
Fig. 1). This method of mutagenesis has been used for
Streptococcus pneumoniae for more than 20 years
(19), and similar methods have been developed for
Streptococcus mutans (41), Bacillus
subtilis (9, 24, 27), and Lactobacillus
species (20, 21). Additionally, plasmid insertion methods
are required for the identification of in vivo-induced genes by the in
vivo expression technology (IVET) and differential fluorescence
induction (DFI) techniques and have been used for the signature-tagged
mutagenesis method in bacteria in which transposons are not functional
(22, 29, 42). Wolfgang et al. have reported the use of
plasmid insertion in gonococci for purposes of in situ cloning of
comP and flanking sequences (45), but the
vector was not optimized for this purpose and the mutagenesis process was not characterized. IDM has several advantages over other methods of
mutagenesis utilized for N. gonorrhoeae. IDM requires only one cloning step for use in mutagenesis, and every clone of chromosomal DNA can be used to make a mutation. Because the mutation is made from
an E. coli plasmid, it is easy to recover the construct that generated a mutation of interest by simply transforming DNA from the
mutant into E. coli. Thus, this method has been used to
identify plasmid clones capable of restoring spontaneous mutants to the wild-type phenotype (8). In addition, with the IDM vectors that we have created for use in N. gonorrhoeae, it is
possible to make both transcriptionally polar and nonpolar mutations.
We have recently discovered the presence of a 60- to 70-kb genetic
island in N. gonorrhoeae. The gonococcal genetic island (GGI) is variable, and certain versions of the GGI are found
significantly more often in N. gonorrhoeae strains isolated
from patients with disseminated gonococcal infections (7).
Within the GGI, there are multiple genes with homology to those of type
IV secretion systems; the greatest similarity is that to the E. coli F-plasmid transfer genes. Type IV secretion systems are
characterized by their unique ability to transfer both DNA and protein
molecules. Well-studied examples of these systems include the DNA
transfer systems of conjugative plasmids, the agrobacterial T-DNA
transfer system, and the pertussis toxin secretion system encoded by
Bordetella pertussis (4, 18).
Gonococci are naturally competent for transformation during all phases
of growth. Although the fine points of gonococcal transformation are
not fully understood, it is known that the recipients must produce
pilin, PilT, and ComP for transformation in N. gonorrhoeae (2, 37, 45). These data suggest a role for pili and
twitching motility in transformation, but their exact role remains
unclear. Gonococcal transformation is dependent on RecA for homologous recombination of transforming DNA in the gonococcal chromosome (17). Both single-stranded and double-stranded DNA, as
well as supercoiled and linear plasmid DNA, have been shown to
transform N. gonorrhoeae (38). However,
transforming DNA must contain the 10-bp neisserial DNA uptake sequence
(DUS) for efficient uptake into a DNase-resistant state
(13). Although significant information is known about the
requirements of the recipient in transformation, little is known about
mechanism of DNA donation. We have recently shown that gonococci
secrete DNA into the medium during growth and that a mutation in a
peptidoglycan hydrolase gene in the GGI (atlA) prevents this
secretion (7). We have also shown that the GGI contains
genes similar to those involved in DNA transfer during conjugation
(7). Here we demonstrate that IDM mutations in these genes
eliminate DNA secretion by growing gonococci. These data suggest that
the GGI encodes a novel type IV secretion system involved in the
donation of DNA for natural transformation.
 |
MATERIALS AND METHODS |
Bacteria and growth conditions.
Bacterial strains and
plasmids used in this study are described in Table
1. E. coli strains were grown
on Luria agar plates or in Luria broth (31) at 37°C.
N. gonorrhoeae strains were grown either in GCBL (1.5%
Proteose Peptone no. 3, 0.4% K2HPO4, 0.1%
KH2PO4, 0.1% NaCl) plus Kellogg's supplements
(16) and 0.042% NaHCO3 (26) at
37°C with aeration or on GCB agar (Difco) plates under 5%
CO2 at 37°C. Erythromycin was used at 10 µg/ml for
gonococci and at 500 µg/ml for E. coli (except where
otherwise indicated) to select for expression of ermC.
Kanamycin was used at 40 µg/ml for E. coli carrying pHSS6
derivatives (35). Chloramphenicol was used at 10 µg/ml
for gonococci, and spectinomycin was used at 75 µg/ml alone and at 50 µg/ml when in combination with chloramphenicol.
DNA techniques.
Gel purification of digested DNA fragments
was performed using GeneClean (Bio 101). Following all ligations,
transformation was performed in chemically competent TOP10 E. coli according to the protocol of the supplier (Invitrogen).
Southern blotting to confirm pIDN insertions was performed according to
standard procedures (31). Chromosomal DNA from N. gonorrhoeae was prepared as described by Boyle-Vavra and Seifert (3). DNA digests were separated by gel electrophoresis in
a 0.8% agarose Tris-borate-EDTA gel. DNA was transferred to a
Stratagene Duralon-UV membrane using a vacuum blotter. Following UV
cross-linking, the chromosomal DNA was probed with digoxigenin-labeled
pIDN4. Blots were washed at high stringency, and chemiluminescent
detection was performed as suggested by the manufacturer (Boehringer Mannheim).
Plasmid screening was performed by whole-cell lysis using the lysis
solution of Kado and Liu (3% sodium dodecyl sulfate in 50 mM Tris [pH
12.6]) (15). Patched E. coli colonies were
lysed in 100 µl of lysis solution, and 20 µl of the lysate was
separated by agarose gel electrophoresis and subsequently stained with
ethidium bromide. Following whole-cell lysis, possible positive
plasmids were isolated and screened further by restriction enzyme
digestion. Plasmid purification was performed as described by Birnboim
and Doly (1).
Plasmid constructions.
pUP1 was linearized with
HindIII, blunted with T4 DNA polymerase, and ligated to the
blunted EcoRI-XbaI fragment from pJD1145 containing the erythromycin resistance gene. Two plasmids carrying kanamycin and erythromycin resistance resulted due to insertion of the
ermC fragment in pUP1 in both orientations (pNH5, forward orientation; pNH5-1, reverse orientation). To remove the kanamycin resistance marker, the plasmids were digested with BamHI and
PvuII, T4 polymerase blunted, and religated. The product
with the forward orientation of ermC was named pNH9, and the
product with the reverse orientation was named pNH9-1.
A polylinker for the pIDN vectors was obtained via PCR of pMOB with
pMOB-polF and pMOB-polR (Tm, 56°C; extension
time, 20 s) (Table 2). The blunted,
polynucleotide kinase (PNK)-treated PCR product was ligated to
NotI/ClaI-digested, T4 polymerase-blunted pNH9
and pNH9-1 to yield four new plasmids containing all possible orientations of erythromycin and the polylinker: pNH9-6, pNH9-7, pNH9-8, and pNH9-9. To make the plasmids smaller, ~200 bp of sequence was removed from pNH9-8 and pNH9-9 by PCR with pORI-F and pGCU-R to
amplify the desired section of each plasmid (Tm,
55°C; extension time, 90 s). PCR products were blunted,
phosphorylated with PNK, and ligated to themselves to form pIDN3 and
pIDN4. EcoRI-SphI fragments from pNH9-6 and
pNH9-7 containing the polylinker and the ermC gene were
cloned into the EcoRI and SphI sites of pNH9-8 and pNH9-9, respectively, to create pIDN1 and pIDN2. The DNA sequence of pIDN4 was determined and was deposited in GenBank under accession number AY034154.
pNH10-1M was created by PCR amplification of MS11A chromosomal DNA
using primers 23F and EndL6R (7), digestion with
AgeI and NsiI, and cloning into the
PstI and XmaI sites of pNH9-9. Subclones of
pNH10-1M were created by deletions of portions of the 890-bp
traG insert and religation of the plasmids. pHH1 was created
by deleting the 0.6-kb HindIII fragment. pHH2 was
created in a similar manner by deleting the
ScaI-EcoRV fragment. pHH3 was created by deletion
of the ScaI-Ecl136II fragment. pHH1, pHH2, and
pHH3 contain 290-, 540-, and 350-bp fragments of the original traG fragment in pNH10-1M, respectively.
pHH15 was constructed in the following manner. The PCR product of
TraH-up (containing an NsiI site) and TraH-down (containing a EcoRV site) (Tm, 66°C; extension
time, 60 s) was cut with NsiI and EcoRV and
cloned into the NsiI and PmeI sites of pGCC6.
This plasmid was linearized with NotI and transformed into
KS16 (traH mutant) for complementation. pGCC6 targets the
inserted gene to a chromosomal location between gonococcal genes
lctP and aspC.
Gonococcal transformation.
Spot transformations of gonococci
were performed as follows: 1 pmol of each plasmid in a 20-µl volume
was spotted in three places on a prewarmed (37°C) GCB agar plate. The
spots were allowed to soak into the plate. A P+ colony of
MS11A was then streaked across the plate through the DNA spots. After
overnight growth at 37°C, colonies were swabbed from the spots with a
Dacron swab and resuspended in 600 µl of GCB. This suspension of
cells was then diluted and plated on both GCB alone and GCB plus
erythromycin, and CFU were counted. Transformation frequencies were
determined as the number of Emr CFU per total CFU.
Spot transformation was also used to make IDM strains. After overnight
growth of the colonies, the spots containing gonococcal transformants
were swabbed onto a GCB-plus-erythromycin plate. These plates were
grown for 1 to 2 days, and individual transformants were restreaked.
DNA release assay.
For DNA release experiments,
P
transparent gonococcal strains were grown overnight on
GCB agar plates. Strains were then inoculated with a sterile Dacron
swab into 3 ml of GCBL medium with Kellogg's supplements
(16) and 0.042% NaHCO3 (26),
with 1 mM isopropyl-
-D-thiogalactopyranoside (IPTG)
added where necessary. These cultures were grown for ~2 to 2.5 h. Cultures were then diluted to an optical density at 540 nm of 0.2 (t = 0 h) in 3 ml of Cellgro Complete tissue
culture medium (Mediatech) with the following supplements: 0.35 mM
cysteine, 0.15 mM cystine, 17.9 mM pyruvate, 0.1% soluble cornstarch,
0.042% NaHCO3, Kellogg's supplements, and 1 mM IPTG where necessary. These cultures were grown for an additional 5 h. Culture
supernatants were collected at 0 and 5 h and were assayed for DNA
release in the following manner. One hundred microliters of a 1:200
dilution of PicoGreen fluorescent dye (Molecular Probes) was added to
100 µl of culture supernatant. DNA release was immediately measured in a fluorometer at an excitation wavelength of 485 nm and an emission
wavelength of 535 nm. DNA release per milliliter of culture over 5 h of growth was then calculated.
DNA release was normalized to the total amount of protein in the
culture, quantified by the Bio-Rad protein assay. A 500-µl portion of
each culture was centrifuged, and the pellet was resuspended in 1 ml of
H2O. Cells were sonicated three times for 10 s each time. One milliliter of a 1:5 dilution of Bio-Rad Dye Reagent Concentrate was added to 20 µl of the sonicated cell solution (in
duplicate). Only gonococcal cultures that had grown ~1 log unit in
5 h of growth were used for analysis of DNA release.
Coculture transformation assay.
Coculture transformation
assays were performed using the P+ gonococcal strain HH507
or HH508 and MS11-Spc that had been grown on GCB agar overnight. Cells
were swabbed into GCBL plus Kellogg's supplements and
NaHCO3 and grown for ~2.5 h at 37°C with aeration. One
milliliter of each culture was then centrifuged and resuspended in 4 ml
of prewarmed, fresh GCBL plus supplements for inoculation (~107 CFU/ml). The following cultures were inoculated
into 3 ml of prewarmed GCBL plus supplements: 1 ml of donor cells
(HH507 or HH508), 1 ml of recipient cells (MS11-Spc), 0.5 ml of donor
cells plus 0.5 ml of recipient cells, and 0.5 ml of donor cells plus 0.5 ml of recipient cells plus 25 µg of DNase/ml. These four cultures were diluted and plated for CFU per milliliter (t = 0 h) on GCB, GCB-chloramphenicol, GCB-spectinomycin, and
GCB-chloramphenicol-spectinomycin plates. Cultures were then grown at
37°C with aeration for 4 h, after which they were again diluted
and plated for CFU per milliliter on plates containing the same
antibiotics as above.
Nucleotide sequence accession number.
The DNA sequence of
pIDN4 has been deposited in GenBank under accession number AY034154.
 |
RESULTS |
Construction of IDM plasmids.
To create an IDM system in
gonococci, we considered several criteria, both of other IDM systems
and of N. gonorrhoeae. The ideal vector for IDM in gonococci
should be nonreplicating in N. gonorrhoeae but should
replicate in E. coli for cloning purposes. The vector should
also have a high transformation rate; efficient DNA uptake in
transformation of N. gonorrhoeae requires the presence of
the 10-bp DUS, which is commonly found in gonococcal and meningicoccal DNA (13). The vector should be small to facilitate
incorporation into the chromosome, since incorporation of heterologous
DNA by gonococci is greatly affected by the length of the heterology (3). In addition, the IDM vector system should have good
selection both in gonococci and in E. coli, a useful
polylinker for cloning, and the capability to produce both polar and
nonpolar insertion-duplication (ID) mutations.
Plasmid pUP1 was used as the starting point for the construction of an
insertion-duplication plasmid because it is a relatively small plasmid
containing the DUS (10), and like most E. coli plasmids, it does not replicate in gonococci. Additionally, unlike many
E. coli cloning vectors, it has no Tn3 resolvase
site, and thus DNA cloned into it could be mutagenized with the
mini-Tn3 transposons developed for shuttle mutagenesis of
gonococci (3, 34). Several factors, however, made pUP1
itself undesirable as an insertional vector for gonococci. The
kanamycin resistance marker is not ideal for selection in gonococci due
to the inherent kanamycin resistance of nonpiliated variants
(12). Also, pUP1 has few sites in the polylinker, and the
neisserial DUS is located within the polylinker, making it possible to
lose the uptake sequence during cloning.
Erythromycin resistance was chosen as the selectable marker for the IDM
plasmids. Erythromycin is preferred over kanamycin because it is a
cleaner selection agent in gonococci. However, E. coli is
inherently resistant to high levels of erythromycin. To increase our
ability to select for transformants containing ermC-carrying
plasmids in E. coli, we constructed an improved promoter for
the ermC gene. The ermC gene in pHSS23 has a
SacI site between the
35 and
10 hexamers, and the vector
contained a perfect
35 sequence in the polylinker region. A deletion
was made in pHSS23 between the ClaI site in the vector and
the SacI site in the ermC promoter to generate a
smaller ermC gene with a consensus sigma-70 promoter that
has a spacing of 16 bp between the
10 and
35 sequences. Thus,
except for the effects of intervening or surrounding sequence, the new
ermC promoter should have a strength similar to that of the
tac promoter, which also has a perfect consensus sequence
and a spacing of 16 bp. This new ermC promoter is strong
enough to read through the ermC transcriptional terminator, and for this reason this marker was used by Mehr et al. to make nonpolar mutations upstream of essential genes in N. gonorrhoeae (23). When the enhanced ermC
was tested for erythromycin resistance, it was found that E. coli cells carrying the construct grew well in media containing
200 to more than 1,000 µg of erythromycin/ml.
The improved ermC was cloned into pUP1 in both orientations.
By creating a plasmid in which transcription will read into the cloned
insert, we will be able to create insertions in the gonococcal chromosome that are effectively nonpolar on downstream genes (Fig. 1). The opposite orientation of
ermC would be more desirable for creating a polar mutation
or when transcription of the insert might result in the production of a
detrimental product. Kanamycin resistance was then removed to make the
vectors smaller, resulting in plasmids pNH9 and pNH9-1.

View larger version (9K):
[in this window]
[in a new window]
|
FIG. 1.
Generation of a nonpolar insertion mutation. IDM results
in a single-crossover recombination event, insertion of the plasmid
into the chromosome, and duplication of homologous sequences. The
strong ermC promoter drives the transcription of downstream
genes.
|
|
To complete the construction, we inserted a polylinker and decreased
the size of the plasmid by removing unnecessary sequence. A 224-bp
region containing a polylinker was obtained by PCR amplification of the
small sequencing and mutagenesis plasmid pMOB (39). The polylinker was cloned in both orientations to facilitate cloning of
fragments in both orientations. This region contains a polylinker with
16 unique sites, as well as binding sites for universal sequencing primers. The region also contains T7 and T3 promoters and could be used
for controlled transcription in certain E. coli strains or
for in vitro transcription. The final step in the constructions was to
eliminate approximately 200 bp of unnecessary DNA between the DUS and
the origin. This was accomplished by PCR of the plasmid and religation.
This resulted in the final plasmid constructs, which we have named
pIDN, for plasmid for IDM of Neisseria (Fig. 2).

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 2.
Plasmid maps of pIDN1 and pIDN3. Plasmids consist only
of the ermC gene, a polylinker, an E. coli origin
of replication, and two copies of the neisserial DUS. pIDN2 and pIDN4
(not shown) are the same as pIDN1 and pIDN3, respectively, differing
only in the orientation of the polylinker.
|
|
Testing IDM in N. gonorrhoeae and generation of GGI
mutants.
Before the completion of the IDM vectors, we tested our
idea that IDM could work efficiently as a method of mutagenesis in N. gonorrhoeae. There are several reasons why IDM might not
work well in gonococci. Gonococci appear to undergo a significant
degree of illegitimate recombination, which can be seen in attempts to knock out essential genes by insertion of an antibiotic resistance marker. These markers are often incorporated, but the essential gene is
duplicated in the transformants, presumably by an illegitimate recombination event (23, 40). Thus, IDM plasmids might be incorporated into arbitrary locations in the chromosome. In addition, N. gonorrhoeae does not efficiently incorporate large
regions of heterologous DNA (3). Thus, plasmid insertion
frequencies might be too low for IDM to be useful. Gonococci are also
known to undergo very high levels of recombination (12,
36). If recombination between the homologous segments of the
insertions in the chromosome were to occur at a high frequency, IDM
mutations would be lost and the method would not be useful for
mutagenesis of N. gonorrhoeae.
During the process of construction of the pIDN vectors, an intermediate
plasmid that contained ermC in the reverse orientation and
the polylinker in the reverse orientation was created. This plasmid,
pNH9-9, was used to test IDM in gonococci. An 890-bp fragment of the
GGI gene, traG, from N. gonorrhoeae strain MS11A was cloned into this intermediate plasmid, and the resulting plasmid was named pNH10-1M. Transformation of gonococci with this plasmid resulted in 2,500 Emr transformants/ml. When transformed
into gonococci, pNH10-1M inserted into the chromosome, resulting in the
traG mutant HH500. Southern analysis confirmed that this
mutant contained the expected insertion of the construct interrupting
traG.
In order for IDM to be a useful method of mutagenesis in gonococci, it
must work with small fragments of genes. It has been found in IDM
systems in other organisms that the size of the chromosomal fragment
within the IDM vector affects transformation frequency (19). We made deletions in pNH10.1-M, resulting in three
plasmids with smaller target regions of DNA: 290-, 540-, and 350-bp
fragments of traG. We found that the length of
traG sequence affected transformation frequency (Table
3). Frequencies ranged from 1.23 × 10
7 to 4.39 × 10
6 transformants/total
CFU (7.21 × 10
8 to 2.09 × 10
6
transformants/µg of plasmid DNA). Plasmids containing smaller fragments resulted in lower frequencies of transformation. However, even the smallest target tested (pHH1, with 290 bp) still attained a
transformation frequency higher than 10
7, well within an
acceptable range for mutagenesis.
The gonococcal strains HH500, HH501, HH502, and HH503, along with two
other IDM strains, KS1 and KS58, were characterized by Southern
blotting to confirm their insertion locations (Fig. 3). The blot was probed with pIDN4. The
further down the chromosome the plasmid is inserted, the larger the
MfeI-NheI fragment is. Except in the case of KS1,
which contains a duplication of the MfeI sites in
traH, as the insert is moved down the chromosome, the
NheI-MfeI fragment grows smaller. In this blot,
as well as other Southern blots of these strains, the mutants were
found to have correctly incorporated insertion plasmids.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 3.
(A) Southern blot of IDM strains KS1, KS58, HH501,
HH502, HH500, and HH503 (lanes 1 through 6, respectively) digested with
MfeI and NheI. This blot was probed with pIDN4,
which binds to the plasmid inserted within the N. gonorrhoeae chromosome. (B) Schematic of N. gonorrhoeae
IDM insertions.
|
|
In a few instances we have identified ID mutants that did not contain
the expected construction. In the process of making nearly 80 plasmid
insertion mutations in the gonococcal island, we have screened 45 gonococcal ID mutants by Southern analysis. Among these we have
obtained only two mutants that did not give the expected restriction
map when analyzed by Southern blotting, and in neither case was the
unusual insertion the only or the predominant type of insertion. Since
the pIDN plasmids contain two copies of the DUS, a sequence repeated
many times in the gonococcal chromosome, these unusual plasmid
insertions may have resulted from recombination at the DUS. We have
also found mutants that contain a duplication of the plasmid insertion.
These double insertions appeared as an additional band the size of the
plasmid on the Southern blot and may result from insertion of a plasmid
dimer formed in E. coli or from a duplication event in the
gonococcal chromosome. Dimers have appeared only twice in all of the
mutants screened.
To estimate the frequency of excision of IDM plasmids from the
gonococcal chromosome, a strain carrying the 890-bp IDM insert in
traG was tested for loss of the plasmid insertion in two
separate experiments. The strain was grown in broth culture for 20 h without erythromycin and then plated onto GCB plates at various
dilutions. After growth overnight, the colonies were replica plated to
plates containing erythromycin and to plates containing no antibiotic. The pattern of colonies produced on the plates was recorded using a
photodocumentation system, and the images were superimposed. We were
unable to detect a single revertant among approximately 105 CFU.
IDM-generated GGI mutants are deficient in DNA release.
The
conventional wisdom is that gonococci donate DNA for transformation by
cell death and autolysis (28, 33); however, our data
suggest that the putative type IV secretion system in the GGI
contributes to DNA donation via specific transport, before autolysis
occurs in culture. Strains with mutations in atlA, a peptidoglycan hydrolase gene in the GGI, were found to be deficient in
DNA donation. AtlA function may be necessary for assembly of the type
IV secretion apparatus (7). Type IV secretion systems characteristically secrete both DNA and protein (4).
Therefore, assaying for DNA released into the extracellular medium can
be used to evaluate the importance of GGI genes in type IV secretion. Nonpolar ID mutants of the GGI genes, traG and
traH (KS59 and KS16, respectively), were tested for the
ability to release DNA into the extracellular medium. Both KS16 and
KS59 were analyzed by Southern blotting and were found to contain the
proper plasmid insertions (data not shown). In addition to these
strains, wild-type, atlA mutant, and plasmid control
gonococci were tested. JD1603, our positive control, contains a plasmid
insert creating a duplication of the beginning of traH
(containing the promoter), resulting in a full copy of the gene. This
mutation was designed to control for any nonspecific effects of having
a pIDN insertion. The traG and traH mutants (KS16
and KS59) exhibited greatly reduced DNA release, with values similar to
those of a DNase-treated control (Fig.
4).

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 4.
DNA released into the medium by gonococcal strains MS11A
(wild type), KS16 (traH mutant), KS59 (traG
mutant), JD1510 (atlA mutant), JD1603 (an intergenic ID
mutant), and HH518 (with traH complementation) during 5 h of growth. For comparison, the supernatant of MS11A was treated for
30 min with DNase. DNA release was normalized to the total amount of
protein. *, P < 0.01; **, P < 0.05; , P < 0.01 compared to KS16 (Student's
t test).
|
|
traH was complemented in trans using a plasmid
construct that targeted the inducible complementing gene to an
irrelevant location on the chromosome of strain KS16. In this construct
traH is under the control of the lac
promoter-operator and can be induced using IPTG. Upon induction, the
ability of the complemented traH mutant HH518, to release
DNA is restored (Fig. 4). Not only does this result demonstrate a
requirement for traH in DNA release; it also shows that the
original traH mutant is effectively nonpolar as we
predicted, i.e., it is not greatly affected with regard to expression
of the downstream genes traG and atlA.
Coculture transformation assays.
We examined gonococcal
strains HH507 and HH508 for the ability to donate DNA for natural
transformation by a coculture transformation assay. In this assay,
donor strains have been made incapable of DNA recombination by a
mutation in recA. Donor strains (Cmr) were mixed
1:1 with the recipient strain (Spr), and after 4 h of
growth, cultures were plated for selection of transformants expressing
both antibiotic resistances. The transformation frequency obtained by
using HH508 as the donor is
50-fold greater than that with HH507
(traG mutant) (Table 4). The
addition of DNase abolishes transformation of the recipient strain by
HH508. These results support the findings (Fig. 4) that the material released from N. gonorrhoeae is DNA and demonstrate the
importance of the type IV secretion of DNA for transformation.
Use of IDM for chromosome walking.
In addition to providing a
convenient method for creating mutations, IDM also facilitates the
cloning of unknown regions of the bacterial chromosome. Morrison et al.
have described its use for this purpose in cloning transformation genes
of S. pneumoniae (25). More recently, plasmids
inserted in the chromosome of Salmonella enterica serovar
Typhimurium were used to clone the genes found to be induced during
infection in a DFI screen (42). We have used our
insertions in the GGI to clone unknown GGI DNA. To clone the region
upstream of traH, a strain containing an insertion at
traH was mapped by Southern blotting to find a reasonably
sized fragment that would contain the plasmid and upstream flanking region. The MfeI fragment was excised from the gel,
purified, and ligated. Transformation of E. coli generated
43 transformants. Screening of 18 of the transformants showed that 17 contained a plasmid of the expected size (data not shown). One of the
18 transformants contained a plasmid identical in size to the plasmid used to make the original insertion. This result suggests that at a low
frequency the plasmid is excising from the chromosome of N. gonorrhoeae or that E. coli can recombine incompletely
digested chromosomal DNA to generate the original plasmid.
DNA sequencing of the region cloned from upstream of traH
revealed the presence of two open reading frames. The first showed no
significant similarity to any sequence in the databases. The second
open reading frame was significantly similar to that encoding TraF of
the E. coli F plasmid. The gonococcal TraF homologue showed 45% similarity and 29% identity with the E. coli TraF,
with similarity extending over nearly the entire length of the
proteins. In E. coli, TraF is a periplasmic protein
necessary for F-pilus assembly and conjugative transfer
(11).
 |
DISCUSSION |
We have characterized the successful use of IDM in N. gonorrhoeae. Using small vectors that we constructed containing as
little as 290 bp of homologous DNA, we observed transformation at
frequencies that are well within the range for successful mutagenesis
and resulted in stable insertion mutations. Using four different-sized fragments of the traG gene, we observed that smaller inserts
gave lower gonococcal transformation frequencies. These data are
consistent with IDM work performed with S. pneumoniae, where
a strong correlation was found between the length of the homologous
sequence and the transformation frequency (19). Although
there have been a few reports of insertional mutagenesis in
Neisseria (30, 45), this is the first report of
plasmids created specifically for IDM of Neisseria and the
first in-depth analysis of the process.
The pIDN plasmids constructed in this study are not only useful in
targeted mutagenesis; they are also useful in chromosome walking, as
shown here for the cloning of traF. Additionally, as part of
an ongoing GGI cloning and sequencing project, we have used the pIDN
plasmids to clone and map approximately 50 kb of the GGI. There is also
potential to use IDM for random insertional mutagenesis in N. gonorrhoeae. Lee et al. have shown that by constructing a library
of IDM vectors containing random 300-bp fragments of S. pneumoniae chromosomal DNA, it is possible to use IDM in a random
mutagenesis method (19). A similar method could be
employed for N. gonorrhoeae.
The IDM mutations in traG and traH have provided
insight into the functions of these genes in N. gonorrhoeae.
traG and traH mutants were shown to release less DNA
into the medium than the wild-type parent during growth. Furthermore, a
traG mutant was shown to be deficient in the ability to
donate chromosomal DNA for natural transformation. This suggests that
these genes play a role in a type IV secretion system encoded within
the genetic island. E. coli TraH and TraG are necessary for
conjugation of the F plasmid. E. coli TraG is involved in
mating pair stabilization, and both TraG and TraH function in
conjugative pilus assembly (11). However, our DNA transfer
in coculture is sensitive to DNase, indicating that the transfer is not
occurring by conjugation (Table 4). Furthermore, the DNA can be
detected in cell-free medium. Thus, these proteins are not functioning
in conjugation. These results raise the question of what the likely
roles of these proteins are in gonococci. F-plasmid TraG is an inner
membrane protein with multiple membrane-spanning segments. It is
essential for DNA transfer and may aid in stabilizing mating contacts
at an early stage of the interaction between donor and recipient cell
surfaces. It has been speculated that TraG may form part of the channel
for DNA transfer during conjugation in E. coli (11). Sequence analysis shows that the GGI traG
has 22% identity and 40% similarity with the E. coli
F-plasmid traG. The gonococcal TraG may also have a role in
the formation of a channel through the membranes by which DNA is
exported into the extracellular medium, composing part of the apparatus
of a type IV secretion system. TraH of the F plasmid is predicted to be
a periplasmic protein involved in F-pilus assembly. It contains an
ATP-binding motif (Walker box), suggesting that it may be involved in
the energetics of assembly or DNA transfer during conjugation. The GGI
TraH also contains a Walker box and has 24% identity and 42% similarity to its F-plasmid homologue. The gonococcal TraH may be
performing a similar function, i.e., assembly of a pilus-like apparatus
involved in DNA release.
Many questions regarding DNA donation and transformation by N. gonorrhoeae are still unanswered. Do the DNA-donating cells die?
We have previously shown that DNA release is observed before autolysis
can be detected, in the early stages of growth, when gonococci are
growing healthily (7). The great advantage of a DNA
donation method would seem to be the ability to release DNA without
having to undergo autolysis and death. The DNA donation system
described here might operate similar to that of an E. coli Hfr, i.e., the gonococcal chromosome may be nicked or cut and the
entire chromosome exported. Alternatively, there may be specific genes
or regions of the chromosome that are transferred. We do not yet know
the size of the DNA being exported or if the exported DNA molecules are
coupled with proteins. Future studies of these questions will enhance
the comprehension of the mechanisms and functions of gonococcal DNA
donation and transformation.
Currently, type IV secretion systems are known to export three types of
substrates: (i)DNA conjugation intermediates (DNA-protein complexes),
(ii) the multisubunit pertussis toxin, and (iii) monomeric proteins
(5). Agrobacterium tumefaciens, the type IV
secretion prototype, transfers T-DNA directly into plant cells and
transfers the proteins VirE2 (a single-stranded binding protein) and
VirF (a virulence factor) as well. The Legionella pneumophila
dot/icm system, also a type IV secretion system, is known to
conjugate RSF1010-related plasmids (IncQ) and presumably secretes
effector molecules to promote survival within macrophages and
free-living amoebae (43). The type IV secretion system of
B. pertussis (composed of ptl gene products) is
known only to secrete a protein substrate (pertussis toxin). Type IV
secretion systems have also been identified in Helicobacter
pylori, Rickettsia prowazekii, Brucella spp., and a
number of nonpathogenic bacteria (5). With the evidence of
both DNA and protein transfer in other type IV secretion systems, further studies of the N. gonorrhoeae GGI and its secretion
system may reveal similar findings of effector molecule or virulence factor secretion.
 |
ACKNOWLEDGMENTS |
We thank Nathan Heerey for technical work on this project.
We also thank the Cremer Fellowship in the Basic Sciences for financial
support of Holly L. Hamilton. This work was supported in part by a
grant to the University of Wisconsin Medical School under the Howard
Hughes Medical Institute Research Resources Program for Medical Schools.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: 1300 University
Ave., 471A MSC, Madison, WI 53706. Phone: (608) 265-2837. Fax: (608) 262-8418. E-mail: jpdillard{at}facstaff.wisc.edu.
 |
REFERENCES |
| 1.
|
Birnboim, H. C., and J. Doly.
1979.
A rapid alkaline extraction procedure for screening recombinant plasmid DNA.
Nucleic Acids Res.
7:1513-1523[Abstract/Free Full Text].
|
| 2.
|
Biswas, G. D.,
T. Sox,
E. Blackman, and P. F. Sparling.
1977.
Factors affecting genetic transformation of Neisseria gonorrhoeae.
J. Bacteriol.
129:983-992[Abstract/Free Full Text].
|
| 3.
|
Boyle-Vavra, S., and H. S. Seifert.
1993.
Shuttle mutagenesis: two mini-transposons for gene mapping and for lacZ transcriptional fusions in Neisseria gonorrhoeae.
Gene
129:51-57[CrossRef][Medline].
|
| 4.
|
Burns, D. L.
1999.
Biochemistry of type IV secretion.
Curr. Opin. Microbiol.
2:25-29[CrossRef][Medline].
|
| 5.
|
Christie, P. J., and J. P. Vogel.
2000.
Bacterial type IV secretion: conjugation systems adapted to deliver effector molecules to host cells.
Trends Microbiol.
8:354-360[CrossRef][Medline].
|
| 6.
|
Dillard, J. P., and H. S. Seifert.
1997.
A peptidoglycan hydrolase similar to bacteriophage endolysins acts as an autolysin in Neisseria gonorrhoeae.
Mol. Microbiol.
25:893-901[CrossRef][Medline].
|
| 7.
| Dillard, J. P., and H. S. Seifert. A
variable genetic island specific for Neisseria gonorrhoeae
is involved in providing DNA for natural transformation and is found
more often in disseminated infection isolates. Mol. Microbiol., in
press.
|
| 8.
|
Dillard, J. P., and J. Yother.
1994.
Genetic and molecular characterization of capsular polysaccharide biosynthesis in Streptococcus pneumoniae type 3.
Mol. Microbiol.
12:959-972[CrossRef][Medline].
|
| 9.
|
Duncan, C. H.,
G. A. Wilson, and F. E. Young.
1978.
Mechanism of integrating foreign DNA during transformation of Bacillus subtilis.
Proc. Natl. Acad. Sci. USA
75:3665-3668.
|
| 10.
|
Elkins, C.,
C. E. Thomas,
H. S. Seifert, and P. F. Sparling.
1991.
Species-specific uptake of DNA by gonococci is mediated by a 10-base-pair sequence.
J. Bacteriol.
173:3911-3913[Abstract/Free Full Text].
|
| 11.
|
Frost, L. S.,
K. Ippen-Jhler, and R. A. Skurray.
1994.
Analysis of the sequence and gene products of the transfer region of the F sex factor.
Microbiol. Rev.
58:162-210[Abstract/Free Full Text].
|
| 12.
|
Gibbs, C. P., and T. F. Meyer.
1996.
Genome plasticity in Neisseria gonorrhoeae.
FEMS Microbiol. Lett.
145:173-179[CrossRef][Medline].
|
| 13.
|
Goodman, S. D., and J. J. Scocca.
1988.
Identification and arrangement of the DNA sequence recognized in specific transformation of Neisseria gonorrhoeae.
Proc. Natl. Acad. Sci. USA
85:6982-6986[Abstract/Free Full Text].
|
| 14.
|
Gunn, J. S., and D. C. Stein.
1996.
Use of a nonselective transformation technique to construct a multiply restriction/modification-deficient mutant of Neisseria gonorrhoeae.
Mol. Gen. Genet.
251:509-517[Medline].
|
| 15.
|
Kado, C. I., and S. T. Liu.
1981.
Rapid procedure for detection and isolation of large and small plasmids.
J. Bacteriol.
145:1365-1373[Abstract/Free Full Text].
|
| 16.
|
Kellogg, D. S., Jr.,
W. L. Peacock,
W. E. Deacon,
L. Brown, and C. I. Pirkle.
1963.
Neisseria gonorrhoeae. Virulence genetically linked to clonal variation.
J. Bacteriol.
85:1274-1279[Abstract/Free Full Text].
|
| 17.
|
Koomey, M., and S. Falkow.
1987.
Cloning of the recA gene of Neisseria gonorrhoeae and construction of gonococcal recA mutants.
J. Bacteriol.
169:790-795[Abstract/Free Full Text].
|
| 18.
|
Krause, S.,
W. Pansegau,
R. Lurz,
F. de la Cruz, and E. Lanka.
2000.
Enzymology of type IV macromolecule secretion systems: the conjugative transfer regions of plasmids RP4 and R388 and the cag pathogenicity island of Helicobacter pylori encode structurally and functionally related nucleoside triphosphate hydrolases.
J. Bacteriol.
182:2761-2770[Abstract/Free Full Text].
|
| 19.
|
Lee, M. S.,
C. Seok, and D. A. Morrison.
1998.
Insertion-duplication mutagenesis in Streptococcus pneumoniae: targeting fragment length is a critical parameter in use as a random insertion tool.
Appl. Environ. Microbiol.
64:4796-4802[Abstract/Free Full Text].
|
| 20.
|
Leenhouts, K. J.,
J. Kok, and G. Venema.
1989.
Campbell-like integration of heterologous plasmid DNA into the chromosome of Lactococcus lactis subsp. lactis.
Appl. Environ. Microbiol.
55:394-400[Abstract/Free Full Text].
|
| 21.
|
Leloup, L.,
S. D. Ehrlich,
M. Zagorec, and F. Morel-Deville.
1997.
Single-crossover integration in the Lactobacillus sake chromosome and insertional inactivation of the ptsI and lacL genes.
Appl. Environ. Microbiol.
63:2117-2123[Abstract].
|
| 22.
|
Mahan, M. J.,
J. M. Slauch, and J. J. Mekalanos.
1993.
Selection of bacterial virulence genes that are specifically induced in host tissues.
Science
259:686-688[Abstract].
|
| 23.
|
Mehr, I. J.,
C. D. Long,
C. D. Serkin, and H. S. Seifert.
2000.
A homologue of the recombination-dependent growth gene, rdgC, is involved in gonococcal pilin antigenic variation.
Genetics
154:523-532[Abstract/Free Full Text].
|
| 24.
|
Michel, B.,
B. Niaudet, and S. D. Ehrlich.
1982.
Intermolecular recombination during transformation of Bacillus subtilis competent cells by monomeric and dimeric plasmids.
Plasmid
10:1-10.
|
| 25.
|
Morrison, D. A.,
M.-C. Trombe,
M. K. Hayden,
G. A. Waszak, and J.-D. Chen.
1984.
Isolation of transformation-deficient Streptococcus pneumoniae mutants defective in control of competence, using insertion-duplication mutagenesis with the erythromycin resistance determinant of pAM 1.
J. Bacteriol.
159:870-876[Abstract/Free Full Text].
|
| 26.
|
Morse, S. A., and L. Bartenstein.
1974.
Factors affecting autolysis of Neisseria gonorrhoeae.
Proc. Soc. Exp. Biol. Med.
145:1418-1421[Medline].
|
| 27.
|
Niaudet, B.,
A. Goze, and S. D. Ehrlich.
1982.
Insertional mutagenesis in Bacillus subtilis: mechanism and use in gene cloning.
Gene
19:277-284[CrossRef][Medline].
|
| 28.
|
Norlander, L.,
J. Davies,
A. Norqvist, and S. Normark.
1979.
Genetic basis for colonial variation in Neisseria gonorrhoeae.
J. Bacteriol.
138:762-769[Abstract/Free Full Text].
|
| 29.
|
Polissi, A.,
A. Pontiggia,
G. Feger,
M. Altieri,
H. Mottl,
L. Ferrari, and D. Simon.
1998.
Large-scale identification of virulence genes from Streptococcus pneumoniae.
Infect. Immun.
66:5620-5629[Abstract/Free Full Text].
|
| 30.
|
Quinn, M. L.,
S. J. Weyer,
L. A. Lewis,
D. W. Dyer, and P. M. Wagner.
1994.
Insertional inactivation of the gene for the meningococcal lactoferrin binding protein.
Microb. Pathog.
17:227-237[CrossRef][Medline].
|
| 31.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 32.
|
Segal, G.,
J. J. Russo, and H. A. Shuman.
1999.
Relationships between a new type IV secretion system and the icm/dot virulence system of Legionella pneumophila.
Mol. Microbiol.
34:799-809[CrossRef][Medline].
|
| 33.
|
Seifert, H. S.,
R. S. Ajioka,
C. Marchal,
P. F. Sparling, and M. So.
1988.
DNA transformation leads to pilin antigenic variation in Neisseria gonorrhoeae.
Nature
336:392-395[CrossRef][Medline].
|
| 34.
|
Seifert, H. S.,
R. S. Ajioka,
D. Paruchuri,
F. Heffron, and M. So.
1990.
Shuttle mutagenesis of Neisseria gonorrhoeae: pilin null mutations lower DNA transformation competence.
J. Bacteriol.
172:40-46[Abstract/Free Full Text].
|
| 35.
|
Seifert, H. S.,
E. Y. Chen,
M. So, and F. Heffron.
1986.
Shuttle mutagenesis: a method of transposon mutagenesis for Saccharomyces cerevisiae.
Proc. Natl. Acad. Sci. USA
83:735-739[Abstract/Free Full Text].
|
| 36.
|
Seifert, H. S., and M. So.
1988.
Genetic mechanisms of bacterial antigenic variation.
Microbiol. Rev.
52:327-336[Free Full Text].
|
| 37.
|
Sparling, P. F.
1966.
Genetic transformation of Neisseria gonorrhoeae to streptomycin resistance.
J. Bacteriol.
92:1364-1371[Abstract/Free Full Text].
|
| 38.
|
Stein, D. C.
1991.
Transformation of Neisseria gonorrhoeae: physical requirements of the transforming DNA.
Can. J. Microbiol.
37:345-349[Medline].
|
| 39.
|
Strathmann, M.,
B. A. Hamilton,
C. A. Mayeda,
M. I. Simon,
E. M. Meyerowitz, and M. J. Palazzolo.
1991.
Transposon-facilitated DNA sequencing.
Proc. Natl. Acad. Sci. USA
88:1247-1250[Abstract/Free Full Text].
|
| 40.
|
Taha, M. K.,
M. So,
H. S. Seifert,
E. Billyard, and C. Marchal.
1988.
Pilin expression in Neisseria gonorrhoeae is under both positive and negative transcriptional control.
EMBO J.
7:4367-4378[Medline].
|
| 41.
|
Tao, L.,
J. M. Tanzer,
H. K. Kuramitsu, and A. Das.
1993.
Identification of several rod loci and cloning of the rodD locus of Streptococcus mutans.
Gene
126:123-128[CrossRef][Medline].
|
| 42.
|
Valdivia, R. H., and S. Falkow.
1997.
Fluorescence-based isolation of bacterial genes expressed within host cells.
Science
277:2007-2011[Abstract/Free Full Text].
|
| 43.
|
Vogel, J. P.,
H. L. Andrews,
S. K. Wong, and R. R. Isberg.
1998.
Conjugative transfer by the virulence system of Legionella pneumophila.
Science
279:873-875[Abstract/Free Full Text].
|
| 44.
|
Wainwright, L. A.,
K. H. Pritchard, and H. S. Seifert.
1994.
A conserved DNA sequence is required for efficient gonococcal pilin antigenic variation.
Mol. Microbiol.
13:75-87[CrossRef][Medline].
|
| 45.
|
Wolfgang, M.,
J. P. M. van Putten,
S. F. Hayes, and M. Koomey.
1999.
The comP locus of Neisseria gonorrhoeae encodes a type IV prepilin that is dispensable for pilus biogenesis but essential for natural transformation.
Mol. Microbiol.
31:1345-1357[CrossRef][Medline].
|
| 46.
|
Zhou, D., and M. A. Apicella.
1996.
Plasmids with erythromycin resistance and catechol 2,3-dioxygenase- or beta-galactosidase-encoding gene cassettes for use in Neisseria spp.
Gene
171:133-134[CrossRef][Medline].
|
Journal of Bacteriology, August 2001, p. 4718-4726, Vol. 183, No. 16
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.16.4718-4726.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Cloud-Hansen, K. A., Hackett, K. T., Garcia, D. L., Dillard, J. P.
(2008). Neisseria gonorrhoeae Uses Two Lytic Transglycosylases To Produce Cytotoxic Peptidoglycan Monomers. J. Bacteriol.
190: 5989-5994
[Abstract]
[Full Text]
-
Garcia, D. L., Dillard, J. P.
(2008). Mutations in ampG or ampD Affect Peptidoglycan Fragment Release from Neisseria gonorrhoeae. J. Bacteriol.
190: 3799-3807
[Abstract]
[Full Text]
-
Kohler, P. L., Hamilton, H. L., Cloud-Hansen, K., Dillard, J. P.
(2007). AtlA Functions as a Peptidoglycan Lytic Transglycosylase in the Neisseria gonorrhoeae Type IV Secretion System. J. Bacteriol.
189: 5421-5428
[Abstract]
[Full Text]
-
da Silva Neto, J. F., Koide, T., Gomes, S. L., Marques, M. V.
(2007). The Single Extracytoplasmic-Function Sigma Factor of Xylella fastidiosa Is Involved in the Heat Shock Response and Presents an Unusual Regulatory Mechanism. J. Bacteriol.
189: 551-560
[Abstract]
[Full Text]
-
Garcia, D. L., Dillard, J. P.
(2006). AmiC Functions as an N-Acetylmuramyl-L-Alanine Amidase Necessary for Cell Separation and Can Promote Autolysis in Neisseria gonorrhoeae.. J. Bacteriol.
188: 7211-7221
[Abstract]
[Full Text]
-
Coady, A. M., Murray, A. L., Elliott, D. G., Rhodes, L. D.
(2006). Both msa Genes in Renibacterium salmoninarum Are Needed for Full Virulence in Bacterial Kidney Disease. Appl. Environ. Microbiol.
72: 2672-2678
[Abstract]
[Full Text]
-
Dillard, J. P., Hackett, K. T.
(2005). Mutations Affecting Peptidoglycan Acetylation in Neisseria gonorrhoeae and Neisseria meningitidis. Infect. Immun.
73: 5697-5705
[Abstract]
[Full Text]
-
Kohler, P. L., Cloud, K. A., Hackett, K. T., Beck, E. T., Dillard, J. P.
(2005). Characterization of the role of LtgB, a putative lytic transglycosylase in Neisseria gonorrhoeae. Microbiology
151: 3081-3088
[Abstract]
[Full Text]
-
Schultheiss, D., Handrick, R., Jendrossek, D., Hanzlik, M., Schuler, D.
(2005). The Presumptive Magnetosome Protein Mms16 Is a Poly(3-Hydroxybutyrate) Granule-Bound Protein (Phasin) in Magnetospirillum gryphiswaldense. J. Bacteriol.
187: 2416-2425
[Abstract]
[Full Text]
-
Gaurivaud, P., Souza, L. C. A., Virgilio, A. C. D., Mariano, A. G., Palma, R. R., Monteiro, P. B.
(2002). Gene Disruption by Homologous Recombination in the Xylella fastidiosa Citrus Variegated Chlorosis Strain. Appl. Environ. Microbiol.
68: 4658-4665
[Abstract]
[Full Text]
-
Cloud, K. A., Dillard, J. P.
(2002). A Lytic Transglycosylase of Neisseria gonorrhoeae Is Involved in Peptidoglycan-Derived Cytotoxin Production. Infect. Immun.
70: 2752-2757
[Abstract]
[Full Text]